Code | 4274D | ||||||||||
MA number | EU/1/18/1286/007 | ||||||||||
Product Form: | sol inj 2x0,4 ml/20 mg (striek.inj.napl.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Sandoz GmbH, Austria | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(4) similar biological application |
MA issued: | 26.07.2018 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 25.01.2024 |